George Lee, MD in Lemont, IL - Anesthesiology

George Lee, MD is a Anesthesiology physician based in Lemont, Illinois. George Lee is licensed to practice in Florida (license number 167646) and his current practice location is 46 Ruffled Feathers Dr, Lemont, Illinois. He can be reached at his office (for appointments etc.) via phone at (630) 800-6888.

NPI number for George Lee is 1114247202 and his current mailing address is 46 Ruffled Feathers Dr, Lemont, Illinois. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1114247202.

Contact Information

	George Lee, MD
	46 Ruffled Feathers Dr, Lemont, IL 60439-7747
	(630) 800-6888
	Not Available

Physician's Profile

Full Name	George Lee
Gender	Male
Speciality	Anesthesiology
Location	46 Ruffled Feathers Dr, Lemont, Illinois
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1114247202
Provider Enumeration Date: 06/11/2010
Last Update Date: 04/25/2024

Medical Identifiers

Medical identifiers for George Lee such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1114247202	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207L00000X	Anesthesiology	167646 (Florida)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. George Lee is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
George Lee, MD 46 Ruffled Feathers Dr, Lemont, IL 60439-7747 Ph: () -	George Lee, MD 46 Ruffled Feathers Dr, Lemont, IL 60439-7747 Ph: (630) 800-6888

News Archive

Discovery Laboratories reports net loss of $6.3 million for second-quarter 2010

Discovery Laboratories, Inc., a biotechnology company developing its novel, synthetic, peptide-containing surfactant and related aerosolization technologies as first in class therapies for severe respiratory diseases, today provides an update on key pipeline and business initiatives and reports financial results for the second quarter ended June 30, 2010.

High bacterial levels in half of lupus skin rashes

A new study published in the Journal of Investigative Dermatology reports that half the skin lesions present in patients with lupus show the presence of viable staph bacteria. This makes them more susceptible to skin infections and also increases the risk that the infection will spread to others.

UChicago Medicine working with Novartis to offer breakthrough gene therapy for pediatric ALL patients

The University of Chicago Medicine is one of a limited number of U.S. sites working to offer a breakthrough gene therapy for pediatric acute lymphoblastic leukemia (ALL), which was just approved by the U.S. Food and Drug Administration.

Fish oil supplements can improve ‘night vision', study shows

Fish oil supplements can significantly improve ‘night vision', according to a new study.

George Lee, MD - Anesthesiology in Lemont, IL